RBC Bearings' fiscal first-quarter earnings and revenues top estimates as aerospace growth, VACCO and wider margins lift results.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
IDEX (IEX) just released second quarter and first half 2026 results, along with an update on its long running share repurchase program, giving investors fresh numbers to evaluate the stock. See our latest analysis for IDEX. Recent earnings and buyback news come as IDEX trades at US$230.45, with the share price up 28.7% year to date and a 1 year total shareholder return of 46.98%. This points to momentum building over the past year despite a modest pullback in the last trading day. If you are...
IDEX Corporation recently reported its second-quarter 2026 results, with sales rising to US$920.6 million from US$865.4 million and diluted EPS from continuing operations increasing to US$1.93 from US$1.74 a year earlier. Alongside higher earnings, IDEX continued to shrink its share count, having repurchased about 25.04% of its stock for roughly US$1.74 billion since 2008, which can amplify per-share metrics over time. With IDEX lifting full-year organic growth and adjusted EPS guidance,...
IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.
Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.
RBC Bearings (RBC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Idex (IEX) and Silgan Holdings (SLGN) have performed compared to their sector so far this year.
IDEX trades at $223.61 and has moved in lockstep with the market. Its shares have returned 13.5% over the last six months while the S&P 500 has gained 8.7%.
Idex (IEX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is how Idex (IEX) and Nordson (NDSN) have performed compared to their sector so far this year.
Is IEX a good stock to buy? We came across a bullish thesis on IDEX Corporation on Valueinvestorsclub.com by angus309. In this article, we will summarize the bulls’ thesis on IEX. IDEX Corporation’s share was trading at $214.93 as of May 1st. IEX’s trailing and forward P/E were 31.79 and 26.04 respectively according to Yahoo Finance. IDEX […]
IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.